Isolated lung perfusion: Single-pass system versus recirculating blood perfusion in pigs

Annals of Thoracic Surgery

Volumn 65, Issue 5, 1998, Pages 1420-1425

  Furrer, Markus ^a   Lardinois, Didier ^b   Thormann, Wolfgang ^b   Altermatt, Hans J ^b   Betticher, Daniel ^b   Cerny, Thomas ^b   Fikrle, Antonin ^b   Mettler, Daniel ^b   Althaus, Ulrich ^b   Burt, Michael E ^b   Ris, Hans Beat ^b  

^a Kantonsspital   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CANNULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; LUNG INJURY; LUNG METASTASIS; LUNG PERFUSION; NONHUMAN; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SURGICAL TECHNIQUE; SWINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOPSY; BLOOD PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DOXORUBICIN; EXTRACORPOREAL CIRCULATION; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HEMORRHAGE; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; LUNG; LUNG DISEASES; LUNG NEOPLASMS; ORGAN SIZE; PEPTIDYL-DIPEPTIDASE A; PULMONARY EDEMA; RADIOPHARMACEUTICALS; SWINE;

EID: 0032076468     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00044-7     Document Type: Article

References (23)

1. 1. Casson AG, Putnam JB, Natarajan G, et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992;69:662-8.
2. 2. Martini N, McCormack PM, Bains MS, Beattie EJJ. Surgery for solitary and multiple pulmonary metastases. N Y State J Med 1978;78:1711-3.
3. 3. Jablons D, Steinberg SM, Roth J, Pittaluga S, Rosenberg SA, Pass HI. Metastasectomy for soft tissue sarcoma. J Thorac Cardiovasc Surg 1989;97:695-705.
4. 4. Lanza LA, Putnam JB Jr, Benjamin RS, Roth JA. Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases. Ann Thorac Surg 1991; 51:219-24.
5. 5. Casper ES, Gaynor JJ, Hajdu SI, et al. A prospective randomized trial of adjuvant chemotherapy with bolus versus continous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors. Cancer 1991;68:1221-9.
6. 6. Potter DA, Glenn J, Kinsella T. Patterns of recurrence in patients with high grade soft-tissue sarcomas. J Clin Oncol 1985;3:353-66.
7. 7. Huth JF, Holmes EC, Vernon SE, Callery CD, Ramming KP, Morton DL. Pulmonary resection for metastatic sarcoma. Am J Surg 1980;140:9-16.
8. 8. Gilman A, Philips FS. Biological actions and therapeutic application of B-chloroethyl amines and sulfides. Science 1946;103:409-15.
9. 9. Weksler B, Lenert J, Ng B, Burt M. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model. J Thorac Cardiovasc Surg 1994;107:50-4.
10. 10. Baciewicz FA Jr, Arredondo M, Chaudhuri B, et al. Pharmacokinetics and toxicity of isolated perfusion of lung with doxorubicin. J Surg Res 1991;50:124-8.
11. 11. Progrebniak HW, Witt CJ, Terrill R, et al. Isolated lung perfusion with tumor necrosis factor: a swine model in preparation of human trials. Ann Thorac Surg 1994;57: 1477-83.
12. 12. Weksler B, Ng B, Lenert JT, Burt ME. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg 1993;56:209-14.
13. 13. Weksler B, Ng B, Lenert JT, Burt ME. Isolated single-lung perfusion: a study of optimal perfusate and other pharmacokinetic factors. Ann Thorac Surg 1995;60:624-9.
14. 14. Krementz ET. Regional perfusion. Current sophistication, what next? Cancer 1986;57:416-32.
15. 15. Johnston MR, Minchin R, Shull JH, et al. Isolated lung perfusion with Adriamycin. A preclinical study. Cancer 1983; 52:404-9.
16. 16. Lienard D, Ewalenko P, Delmotti JJ, Renard N, Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992;10:52-60.
17. 17. Jacobs JK, Flexner JM, Scott HW Jr. Selective isolated perfusion of the right or left lung. J Thorac Cardiovasc Surg 1961;42:546-52.
18. 18. Awad JA, Chenard J, Lemieux JM, Lou W. Evaluation of various fluids for the perfusion of the canine pulmonary lobes. Dis Chest 1965;48:269-77.
19. 19. Wang HY, Bruce Ng, Blumberg D, Port JL, Hochwald SN, Burt ME. Pulmonary artery perfusion of doxorubicin with blood flow occlusion: pharmacokinetics and treatment in a metastatic sarcoma model. Ann Thorac Surg 1995;60:1390-4.
20. 20. Hollinger MA, Giri SN, Patwell S, Zuckermann JE, Gorin A, Parsons G. Effect of acute lung injury on angiotensin converting enzyme in serum, lung lavage, and effusate. Am Rev Respir Dis 1980; 121:373-6.
21. 21. Kelley J. Lavage angiotensin-converting enzyme as a marker of lung injury. Am Rev Respir Dis 1988;137:531-4.
22. 22. De Jongh RF, De Backer WA, Mohan R, Jorens PG, van Overveld FJ. Angiotensin-converting enzyme activity in serum and bronchoalveolar lavage fluid after damage to the alveolo-capillary barrier in the human lung. Intensive Care Med 1993;19:390-4.
23. 23. Creasey WA, McIntosh LS, Brescia T, et al. Clinical effects and pharmacokinetics of different dosage schedules of Adriamycin. Cancer Res 1976;36:216-21.